J. Goldman & CO LP Cumberland Pharmaceuticals Inc Transaction History
J. Goldman & CO LP
- $3.8 Billion
- Q1 2025
A detailed history of J. Goldman & CO LP transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, J. Goldman & CO LP holds 241,481 shares of CPIX stock, worth $1.14 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
241,481Holding current value
$1.14 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CPIX
# of Institutions
39Shares Held
4.42MCall Options Held
185KPut Options Held
6.8K-
Israel Englander Millennium Management LLC | New York, Ny810KShares$3.81 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX740KShares$3.49 Million0.44% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny503KShares$2.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA417KShares$1.96 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX252KShares$1.19 Million0.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $69.1M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...